comparison of different treatment modalities in management of wart
Not Applicable
- Conditions
- Health Condition 1: null- multiple viral warts
- Registration Number
- CTRI/2018/02/012019
- Lead Sponsor
- krishna b bhalala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. multiple viral warts over the body
Exclusion Criteria
i.Pregnant and lactating mothers.
ii.Immunocompromised patients.
iii.Known hypersensitivity to antigens.
iv.Ulcerated/inflamed/secondarily infected warts.
v.Patients not consenting to the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method complete clearance of the lesionsTimepoint: lesion site will assessed at the end of 8 weeks
- Secondary Outcome Measures
Name Time Method side effects(pain, fever,severe odema)Timepoint: 2 weeks, 4 weeks and 6 weeks